StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.85−0.06 (-2.06%)

Close on Nov 17, 2026Market cap $28.36MP/E –Yield –

Scynexis cash

Cash and short-term investments held at the end of each period.

Scynexis's cash was $71.10M at Jun 30, 2026. For fiscal 2025 it was $56.30M, down 25.0% from the year before. Over ten years it grew 1.8% a year on average. The highest annual figure on record is $104.70M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$56.30M-25.0%
FY2024Dec 31, 2024$75.10M-23.4%
FY2023Dec 31, 2023$98.00M+33.3%
FY2022Dec 31, 2022$73.50M-29.8%
FY2021Dec 31, 2021$104.70M+12.2%
FY2020Dec 31, 2020$93.31M+121.2%
FY2019Dec 31, 2019$42.19M+258.6%
FY2018Dec 31, 2018$11.77M+2.6%
FY2017Dec 31, 2017$11.47M-80.4%
FY2016Dec 31, 2016$58.59M+24.7%
FY2015Dec 31, 2015$46.99M+45.7%
FY2014Dec 31, 2014$32.24M+2199.8%
FY2013Dec 31, 2013$1.40M-41.2%
FY2012Dec 31, 2012$2.39M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$71.10M+52.9%
Q1 FY2026Mar 31, 2026$72.40M+34.6%
Q4 FY2025Dec 31, 2025$56.30M-25.0%
Q3 FY2025Sep 30, 2025$37.90M-55.4%
Q2 FY2025Jun 30, 2025$46.50M-44.4%
Q1 FY2025Mar 31, 2025$53.80M-42.9%
Q4 FY2024Dec 31, 2024$75.10M-23.4%
Q3 FY2024Sep 30, 2024$84.90M-19.3%
Q2 FY2024Jun 30, 2024$83.70M-8.9%
Q1 FY2024Mar 31, 2024$94.20M+71.9%
Q4 FY2023Dec 31, 2023$98.00M+33.3%
Q3 FY2023Sep 30, 2023$105.20M+9.5%
Q2 FY2023Jun 30, 2023$91.90M-22.7%
Q1 FY2023Mar 31, 2023$54.80M-42.6%
Q4 FY2022Dec 31, 2022$73.50M-29.8%
Q3 FY2022Sep 30, 2022$96.10M-4.2%
Q2 FY2022Jun 30, 2022$118.91M+5.5%
Q1 FY2022Mar 31, 2022$95.43M+3.4%
Q4 FY2021Dec 31, 2021$104.70M+12.2%
Q3 FY2021Sep 30, 2021$100.33M+237.0%
Q2 FY2021Jun 30, 2021$112.72M+228.7%
Q1 FY2021Mar 31, 2021$92.28M+349.6%
Q4 FY2020Dec 31, 2020$93.31M+121.2%
Q3 FY2020Sep 30, 2020$29.77M+150.3%
Q2 FY2020Jun 30, 2020$34.29M+76.1%
Q1 FY2020Mar 31, 2020$20.53M+54.6%
Q4 FY2019Dec 31, 2019$42.19M+258.6%
Q3 FY2019Sep 30, 2019$11.89M-27.5%
Q2 FY2019Jun 30, 2019$19.48M+174.5%
Q1 FY2019Mar 31, 2019$13.28M-51.8%
Q4 FY2018Dec 31, 2018$11.77M+2.6%
Q3 FY2018Sep 30, 2018$16.41M+87.5%
Q2 FY2018Jun 30, 2018$7.10M-4.7%
Q1 FY2018Mar 31, 2018$27.55M-49.8%
Q4 FY2017Dec 31, 2017$11.47M-80.4%
Q3 FY2017Sep 30, 2017$8.75M-70.6%
Q2 FY2017Jun 30, 2017$7.45M–
Q1 FY2017Mar 31, 2017$54.90M–
Q4 FY2016Dec 31, 2016$58.59M–
Q3 FY2016Sep 30, 2016$29.81M–

More Scynexis figures

See a number that looks wrong?